Global Custom Market Research Reports Provider Company

phone

Acticor Biotech SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 21
  • Category: Pharmaceuticals
  • Country: France
Summary

Acticor Biotech SAS (Acticor), a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company provides Fab product that provides monoclonal antibody targeting solutions through platelet glycoprotein VI, which is a protein cloned in the INSERM unit U1148. Its Fab finds application in the area of antithrombic treatments and that is suitable for even to treat thrombolysis patients. The companys products are used through stems from sheer need for new therapeutic options to manage stroke. It markets its products through its network of distributors in France. Acticor is headquartered in Paris, France.

Acticor Biotech SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acticor Biotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Acticor Biotech Raises USD2 Million in Venture Financing 10
Acticor Biotech Raises Additional USD1.6 Million in Venture Financing 11
Acticor Biotech Raises USD1.6 Million in Venture Financing 12
Acticor Biotech Raises USD0.7 Million in Seed Financing 13
Partnerships 14
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 14
Acticor Biotech Enters into Agreement with Catalent 15
Licensing Agreements 16
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 16
Acticor Biotech SAS - Key Competitors 17
Acticor Biotech SAS - Key Employees 18
Acticor Biotech SAS - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Clinical Trials 20
Feb 23, 2017: Acticor Biotech Has Selected Its Contract Research Organisation to Manage Clinical Study Phase I 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables

List of Tables
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Key Facts 2
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acticor Biotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acticor Biotech SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Acticor Biotech Raises USD2 Million in Venture Financing 10
Acticor Biotech Raises Additional USD1.6 Million in Venture Financing 11
Acticor Biotech Raises USD1.6 Million in Venture Financing 12
Acticor Biotech Raises USD0.7 Million in Seed Financing 13
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 14
Acticor Biotech Enters into Agreement with Catalent 15
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 16
Acticor Biotech SAS, Key Competitors 17
Acticor Biotech SAS, Key Employees 18
Acticor Biotech SAS, Other Locations 19

List Of Figures

List of Figures
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Acticor Biotech SAS (Acticor), a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company provides Fab product that

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports